Viral tropism and the pathogenesis of influenza in the Mammalian host.

Influenza viruses, single-stranded negative-sense RNA viruses within the family Orthomyxoviridae, remain an important cause of human morbidity and mortality worldwide. Despite effective vaccines, more than 200,000 individuals in the United States are hospitalized each year for influenza, and approximately 35,000 succumb to disease.1 Seasonal epidemics arise through antigenic variation and recombination events from existing and currently circulating human strains, which initially target the upper respiratory tract with extension to a bronchointerstitial pneumonia in a subset of affected individuals. Disease is often more severe in older and debilitated patients, producing a characteristic distribution in age-related mortality within the affected population.2 In contrast to seasonal epidemics, pandemics arise when antigenically novel viruses emerge and are readily transmissible within the naive human population. Such events are rare and occur after zoonotic transmission of viruses through recombination events between established human and avian strains or possibly through direct adaptation of avian strains for efficient human to human transmission.3 Concerns over an avian influenza pandemic have risen since 1997 with the recognition of H5N1 as a cause of fulminant disease in humans.4,5 Pathologically fatal H5N1 causes diffuse alveolar damage and progression to multiple organ dysfunction with a case fatality rate estimated at more than 50%. Although H5N1 disease is severe, transmission rates have been low, and viral adaptation to efficient human to human transmission has not occurred. Understanding viral and host barriers that prevent transmission may be critical in establishing rational control measures as well as predicting and stratifying risk for individual strains of influenza. In this issue of The American Journal of Pathology, van Riel et al6 examine the viral binding distribution in pulmonary tissue of a number of avian and human influenza strains to elucidate the role of tropism in transmission and pathogenesis.

[1]  David J. Stevens,et al.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors , 2006, Nature.

[2]  T. Kuiken,et al.  Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis) , 2003, Veterinary pathology.

[3]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[4]  R. Webster,et al.  Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. , 1998, The Journal of infectious diseases.

[5]  K. Ungchusak,et al.  Apoptosis and Pathogenesis of Avian Influenza A (H5N1) Virus in Humans , 2007, Emerging infectious diseases.

[6]  S. Dowell,et al.  A child with avian influenza A (H5N1) infection. , 2005, The Pediatric infectious disease journal.

[7]  G. Garnett,et al.  ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES , 2006 .

[8]  T. Kuiken,et al.  Immunopathology and Infectious Diseases Influenza A Virus ( H 5 N 1 ) Infection in Cats Causes Systemic Disease with Potential Novel Routes of Virus Spread within and between Hosts , 2005 .

[9]  Yong Poovorawan,et al.  Avian Influenza H5N1 in Tigers and Leopards , 2004, Emerging infectious diseases.

[10]  Ian A. Wilson,et al.  Glycan microarray technologies: tools to survey host specificity of influenza viruses , 2006, Nature Reviews Microbiology.

[11]  Yi Guan,et al.  Avian Influenza Virus (H5N1): a Threat to Human Health , 2007, Clinical Microbiology Reviews.

[12]  Thijs Kuiken,et al.  H5N1 Virus Attachment to Lower Respiratory Tract , 2006, Science.

[13]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[14]  Ian A. Wilson,et al.  Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.

[15]  H. Klenk,et al.  Human and avian influenza viruses target different cell types in cultures of human airway epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Guan,et al.  Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract , 2007, Nature Medicine.

[17]  J. Nicholls,et al.  Influenza A H5N1 Replication Sites in Humans , 2005, Emerging infectious diseases.

[18]  Thijs Kuiken,et al.  Avian H5N1 Influenza in Cats , 2004, Science.

[19]  Thomas Rowe,et al.  Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets , 2002, Journal of Virology.

[20]  T. Kuiken,et al.  Pathogenesis of Influenza A (H5N1) Virus Infection in a Primate Model , 2001, Journal of Virology.

[21]  Y. Guan,et al.  Studies of H5N1 Influenza Virus Infection of Pigs by Using Viruses Isolated in Vietnam and Thailand in 2004 , 2005, Journal of Virology.

[22]  Yoshihiro Kawaoka,et al.  Avian flu: Influenza virus receptors in the human airway , 2006, Nature.

[23]  R. Sung,et al.  Pathology of fatal human infection associated with avian influenza A H5N1 virus , 2001, Journal of medical virology.

[24]  R. Webster,et al.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.

[25]  Ron A M Fouchier,et al.  Immunopathology and Infectious Disease Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals , 2010 .

[26]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[27]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.